Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide.

Document Type

Article

Publication Title

Bone marrow transplantation

DOI

10.1038/s41409-026-03082-x

Publication Date

10-29-2026

Share

COinS